These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 26942997)

  • 1. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
    Ma Z; Wang N; He H; Tang X
    J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
    Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
    Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes.
    Leung MH; Harada T; Kee TW
    Curr Pharm Des; 2013; 19(11):2070-83. PubMed ID: 23116313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect.
    Yadav YC; Pattnaik S; Swain K
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1889-1895. PubMed ID: 31549866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
    Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
    Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving curcumin solubility and bioavailability by encapsulation in saponin-coated curcumin nanoparticles prepared using a simple pH-driven loading method.
    Peng S; Li Z; Zou L; Liu W; Liu C; McClements DJ
    Food Funct; 2018 Mar; 9(3):1829-1839. PubMed ID: 29517797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.
    Ipar VS; Dsouza A; Devarajan PV
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):459-480. PubMed ID: 30771095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo anti-diabetic and wound healing potential of chitosan/alginate/maltodextrin/pluronic-based mixed polymeric micelles: Curcumin therapeutic potential.
    Akbar MU; Zia KM; Akash MSH; Nazir A; Zuber M; Ibrahim M
    Int J Biol Macromol; 2018 Dec; 120(Pt B):2418-2430. PubMed ID: 30195611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.
    Harigae T; Nakagawa K; Miyazawa T; Inoue N; Kimura F; Ikeda I; Miyazawa T
    Int J Nanomedicine; 2016; 11():3009-22. PubMed ID: 27418823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
    Kharat M; McClements DJ
    J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies.
    Mirzaei H; Shakeri A; Rashidi B; Jalili A; Banikazemi Z; Sahebkar A
    Biomed Pharmacother; 2017 Jan; 85():102-112. PubMed ID: 27930973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
    Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
    Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
    Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-dried curcumin nanoemulsion: A new road to improvement of oral bioavailability of curcumin.
    Hu L; Hu Q; Yang C
    Pak J Pharm Sci; 2018 Jan; 31(1):169-173. PubMed ID: 29348099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmaceutical nanoformulations for curcumin: Enhancement of aqueous solubility and carrier retention.
    Allijn IE; Schiffelers RM; Storm G
    Int J Pharm; 2016 Jun; 506(1-2):407-13. PubMed ID: 27139142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.